FEFuat Erel

Fuat Erel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fuat Erel has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association Between Obstructive Sleep Apnea Severity and Cardiometabolic Index in the Context of Cardiovascular Risk

    by Mustafa Colak, Hikmet Coban, Merve Yumrukuz Senel, Gulcin Yilmaz, Nurhan Sarioglu, Fuat Erel

    Amaç: Çalışmamız, Kardiyometabolik İndeks (KMİ) ile Obstrüktif Uyku Apne (OUA) arasındaki ilişkiyi değerlendirmeyi ve kardiyovasküler risk değerlendirmesindeki potansiyel klinik önemini araştırmayı amaçlamaktadır. Gereç ve Yöntemler: Ocak 2022 ile Temmuz 2023 tarihleri arasında uyku apnesi ön tanısıyla polisomnografi (PSG) uygulanan toplam 158 hasta çalışmaya dahil edildi. Demografik veriler, antropometrik ölçümler, eşlik eden hastalıklar, biyokimyasal parametreler ve KMİ değerleri analiz edildi. Bulgular: Çalışmaya 112'si erkek (%70,9) olmak üzere toplam 158 hasta alındı. Kardiyometabolik indeks değerlerinin, OUA şiddeti arttıkça anlamlı derecede yükseldiği saptandı (p=0,03). Apne-hipopne indeksi ile KMİ arasında düşük düzeyde pozitif korelasyon bulundu (r=0,21, p<0,001, %95 GA: 0,001-0,020). Ağır OUA olan hastalar ile basit horlama olan hastalar arasında KMİ değerlerinde 0,88 birimlik mutlak fark tespit edildi. Kardiyometabolik indeks, kardiyovasküler hastalığı olan hastalarda daha yüksek saptanmasına rağmen, aralarında anlamlı derecede fark bulunmadı (p=0,385). Sonuç: Obstrüktif uyku apnesi şiddeti ile KMİ arasında anlamlı pozitif bir ilişki saptadık. Kardiyometabolik indeksin, uyku apnesi olan hastalarda kardiyovasküler riskle ilişkili olumsuz kardiyometabolik profili yansıtan basit ve pratik bir belirteç olarak kullanılabileceğini öne sürüyoruz.

  • Open Access

    Artificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients?

    by Merve Yumrukuz Şenel, Emine Ayan, Mustafa Çolak, Hikmet Çoban, Fuat Erel, Nurhan Sarıoğlu

    SUMMARY OBJECTIVE: The aim of this study was to determine the quality, reliability, and readability of the responses provided by artificial intelligence chatbots about idiopathic pulmonary fibrosis. METHODS: The clinically relevant questions about idiopathic pulmonary fibrosis diagnosis, treatment, prognosis, and lifestyle management were submitted to four widely used artificial intelligence chatbots, including ChatGPT, Perplexity, Gemini, and Copilot. Responses were assessed by five clinicians based on readability, understandability, quality, and content reliability using standardized tools. RESULTS: The overall readability of chatbot-generated responses was low, corresponding to high educational requirements. Understandability ranged from moderate to good, whereas actionability remained moderate. Gemini produced the most readable and understandable outputs. Journal of the American Medical Association and Likert scores indicated limited source transparency but good guideline concordance. DISCERN analysis for the treatment question showed significant variation (p=0.003), with Perplexity achieving the highest total score. CONCLUSION: Although artificial intelligence chatbots offer rapid and accessible information, their readability and source reliability remain limited. These findings highlight the necessity of expert supervision and further model improvement before artificial intelligence chatbots can be safely integrated into patient education.


  • Can CPAP therapy alter nasolacrimal duct drainage in patients with obstructive sleep apnea??

    by Kamil Gokce Tulaci, Nurhan Sarioglu, Gözde Sahin Vural, Erhan Arslan, Hasan Canakci, Tugba Tulaci, Fuat Erel, Hasmet Yazici

    Purpose To investigate whether the use of continuous positive airway pressure (CPAP) therapy due to obstructive sleep apnea (OSA) affects the nasolacrimal duct (NLD) drainage. Methods In this prospective study, group 1 included 82 NLDs from 41patients with OSA who were treated with CPAP at least 6 months to 2 years. Group 2 included 68 NLDs from 34 patients with OSA who received no CPAP therapy. Group 3 included 70 NLDs from 35 healthy volunteers, with no nasal/paranasal or nasolacrimal system problems. Nasolacrimal drainage times of participants in all groups were measured by observing the fluorescein-containing eye drops administered into the eye via endoscopic visualization of Hasner’s valve area. The time of nasolacrimal drainage was compared between the three groups. The correlation of NLD drainage time with PAP pressure and CPAP usage was investigated. Results The NLD drainage time of group 1 was significantly shorter compared both to the group 2 (p = 0.001) and group 3 (p < 0.001). Correlation analysis revealed a statistically significant negative correlation between NLD drainage time and CPAP pressure (p < 0.01, r = − 0.305) and no correlation between NLD drainage time and CPAP treatment duration (p = 0.304, r = 0.115). Conclusion CPAP usage changes NLD drainage time in patients with OSA who regularly use CPAP.

  • Open Access

    Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis?

    by Hikmet Coban, Mustafa Colak, Merve Yumrukuz Şenel, Muzaffer Gunes, Nurhan Sarioglu, Fuat Erel

  • Are the serum iron parameters related to the severity of obstructive sleep apnea syndrome?

    by Merve Yumrukuz Şenel, Rabia Şahin, Mustafa Çolak, Hikmet Çoban, Fuat Erel, Nurhan Sarıoğlu

    Purpose To evaluate the correlation and relationship between iron parameters including serum iron level, iron-binding capacity, ferritin, transferrin saturation, and the severity of OSAS in the patients who underwent polysomnography. Methods We retrospectively reviewed 209 patients and divided the patients into two groups; AHI ≥ 30 and AHI < 30. The groups were compared using the Mann-Whitney U and the chi-square test. In addition, Spearman’s correlation analysis was performed to analyze the correlation between AHI and iron parameters. Results The mean age of the patients was 47.9 ± 13.7 (19–89) years. Of the 209 patients, 40.7% (n = 85) were female and 59.3% (n = 124) were male. Iron and transferrin saturation was significantly lower in the patients with AHI ≥ 30 compared to the patients with AHI < 30. In female patients, there wasn’t any correlation between AHI and iron, ferritin, transferrin saturation, and iron-binding capacity. But, there was a significant negative correlation between the AHI and iron (r = -0.292, p = 0.001) and transferrin saturation (r = -0.349, p < 0.001) in male patients. Also, the AHI was significantly positively correlated with iron binding capacity (r = 0.307, p = 0.001) in male patients. Conclusion Our results showed that iron levels were lower in severe OSAS. Suggesting that iron levels decrease as a result of oxidative stress and inflammation seen in OSAS, iron parameters may be a good biomarker in OSAS patients.


  • Open Access

    Comparison of PPD and IGST Sensitivity in Latent Tuberculosis Assessment (Cross-sectional Study)

    by Fuat Erel, Nurhan Sarıoğlu, Nilay Şahin, Mustafa Çolak, Kazım Batıhan Büyükzengin, Hikmet Çoban

    Objective: Purified Protein Derivative (PPD) and Interferon Gamma Release Assay (IGRA) were performed on patients with ankylosing spondylitis and rheumatoid arthritis who were planned to initiate immunosuppressive treatment. The aim was to determine which test would be more appropriate for diagnosing latent tuberculosis (TB) and to evaluate the sensitivity and specificity of PPD and IGRA tests in latent TB diagnosis. Materials and Methods: Forty-seven patients with rheumatoid arthritis and 27 patients with ankylosing spondylitis were included in the study. All patients underwent both PPD and QuantiFERON-TB Gold Plus testing. Latent TB was defined as close contact with active tuberculosis infection and/or presence of suspicious fibrotic/calcified lesions on chest radiography without active tuberculosis infection. Results: The QuantiFERON-TB Gold Plus test demonstrated a specificity of 96.6% and sensitivity of 73.3%, while the tuberculin skin test (TST) showed a specificity of 25.4% and sensitivity of 93.3%. A significant correlation was found between the QuantiFERON-TB Gold Plus test and latent tuberculosis criteria (p<0.001, r=0.562), whereas no statistically significant correlation existed between TST and latent tuberculosis criteria (p=0.309, r=0.120). Conclusion: The IGRA test demonstrated higher specificity and sensitivity compared to TST. Given the lower specificity of TST observed in our study compared to other studies, the IGRA test may be recommended for patients planned to receive prophylactic treatment.

  • Open Access

    The Effect of Pulmonary Rehabilitation on Echocardiographic Parameters and Quality of Life in Patients with Primary Lung Disease

    by Özgen Şafak, Sabri Serhan Olcay, Didar Elif Akgün, Abdulrahman Naser, Fuat Erel, Eyüp Avcı

    The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.

  • Open Access

    Could the HALP score serve as a biomarker of bronchiectasis exacerbation?

    by Mustafa Çolak, Hikmet Çoban, Nurhan Sarioğlu, Merve Yumrukuz Şenel, Fuat Erel

    Bronchiectasis is a chronic inflammatory lung disease and patients may occasionally experience acute exacerbations. Our study aims to determine the relationship between exacerbation periods and HALP (hemoglobin, albumin, lymphocyte, platelet) scores in patients with bronchiectasis. Adult patients diagnosed with bronchiectasis and followed up in our clinic between 02.2020-12.2022 were retrospectively evaluated. After the examinations, the effect of bronchiectasis exacerbation on the HALP score was investigated. A total of 84 patients diagnosed with non-cystic fibrosis bronchiectasis were included in our study. 42 of the patients were male (50%), and 42 were female. The average age of all patients was 52.37 ± 16.2. 35 patients (41.7%) were in the exacerbation period, and 49 patients (58.3%) were in the stable period. The median values of leukocytes, neutrophils, and C-reactive protein (CRP) were significantly higher in patients during the exacerbation period compared to the stable period (respectively p= 0.00, p= 0.00, p= 0.00). The average values of FEV1% and FVC% in patients during the exacerbation period were significantly lower compared to the stable period (p= 0.03, p= 0.00, respectively). The HALP score was significantly lower in patients during the exacerbation period compared to the stable period (p= 0.00). A significant negative correlation was found between the HALP score and leukocytes, neutrophils, and CRP (p= 0.00, p= 0.00, p= 0.00, respectively). Also, a significant positive correlation was found between the HALP score and FEV1% and FVC% (p= 0.00, p= 0.00, respectively). Our study revealed that the HALP score is associated with infectious and pulmonary functional parameters in bronchiectasis patients in the exacerbation period. We propose that the HALP score could serve as a valuable biomarker during exacerbations.


  • Open Access

    Response to “Clinical and radiological outcomes of long COVID and post-COVID fibrosis: Correspondence”

    by Nurhan Sarıoğlu, Gülden Deniz Aksu, Hikmet Çoban, Erdoğan Bülbül, Gülen Demirpolat, Ayşegül Tuğçe Arslan, Fuat Erel

  • Open Access

    Clinical and radiological outcomes of long-COVID: Is the post-COVID fibrosis common?

    by Nurhan Sarıoğlu, Gülden Deniz Aksu, Hikmet Çoban, Erdoğan Bülbül, Gülen Demirpolat, Ayşegül Tuğçe Arslan, Fuat Erel

    COVID-19 survivors may take longer to regain full well-being. This study aimed to investigate clinical and functional evaluation and radiologic changes in the third month after COVID-19. A total of 126 patients were assessed in the third month for symptoms, pulmonary function, exercise capacity, radiologic imaging, and quality of life after being discharged following COVID-19 treatment. Two radiologists evaluated the initial and follow-up images. At the third month follow-up visit, the most common persisting symptoms were shortness of breath (32.5%), cough (12.7%), and muscle pain (12.7%). At the follow-up visit, oxygen saturations at rest and after a sixmin walking test were lower in patients with prior intensive care hospitalization compared to those without (p<0.001, p= 0.004). Computed tomography (CT) scans revealed persisting pulmonary pathologies in 64.6% of patients at the third month follow-up. The most common pathologies on follow-up thoracic CT were fibrotic-like changes in 44.2% and ground-glass opacities (GGO) in 33.3%. Regression analysis unveiled that age [95% confidence interval (CI), 1.01 to 1.15; p= 0.020], male sex (95% CI, 4.06 to 95.3, p<0.001), first CT severity score (95% CI, 1.02 to 1.41, p= 0.028), duration of hospitalization (95% CI, 1.02 to 1.18, p= 0.012), oxygen saturation (95% CI, 0.86 to 0.96, p<0.001) were independent predictors of fibrotic-like changes. In the third month following COVID-19, the most common symptom was dyspnea, and the most common radiological findings were fibrotic-like changes and GGO. Longer follow-up studies of COVID-19 survivors are needed to observe lasting changes.